Table 3. Ability of nuclear β-catenin expression to differentiate paediatric fibromatosis from fibrosarcoma.
Proportion of tumour cells exhibiting nuclear β-catenin expression | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|
Cut-off (25%) | 85.7% | 62.5% | 66.6% | 83.3% |
Cut-off (50%) | 75% | 45.4% | 33.3% | 83.3% |
PPV, positive predictive value; NPV, negative predictive value.